Indian drugmaker Sun Pharmaceuticals has announced that it has got approval from the U.S. regulatory authorities to market a generic version of GlaxoSmithKline's Wellbutrin SR extended release tablets.
The company, which is in trouble in Israel, said that the FDA approved its application to market a generic version of Wellbutrin on Thursday.
AdvertisementWellbutrin is an antidepressant medication and works in the brain to treat major depressive disorder and seasonal affective disorder
P Boy Searches for Lost Relatives After Losing Parents to Cancer Oxytocin can be the New Treatment for Social Problems in Autism: Study M
You May Also Like